Follow-up of benign thyroid nodules confirmed by ultrasound-guided core needle biopsy after inconclusive cytology on fine-needle aspiration biopsy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hwang, Yoon Ji | - |
dc.contributor.author | Koo, Hye Ryoung | - |
dc.contributor.author | Park, Jeong Seon | - |
dc.date.accessioned | 2023-05-03T11:16:03Z | - |
dc.date.available | 2023-05-03T11:16:03Z | - |
dc.date.created | 2023-01-05 | - |
dc.date.issued | 2023-01 | - |
dc.identifier.issn | 2288-5919 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/185195 | - |
dc.description.abstract | Purpose: The goal of this study was to follow benign thyroid nodules confirmed by ultrasound (US)-guided core needle biopsy (CNB) after inconclusive cytology on fine-needle aspiration (FNA) biopsy. Methods: Sixty-two thyroid nodules from 62 patients with CNB-confirmed benign histology that initially had inconclusive cytology on FNA were retrospectively included. The thyroid nodules were followed for 38.7 months (median, 27.5 months; range, 6 to 101 months), and the US findings of biopsied nodules, such as the interval change in size, US characteristics, and imaging category based on the Korean Thyroid Imaging Reporting and Data System (K-TIRADS), were evaluated. In addition, patients’ clinical records were reviewed for any further management or newly diagnosed thyroid malignancy. Results: Among 62 cases, three (4.8%) showed interval size growth, while 59 (95.2%) demonstrated no interval change or a decrease in size. There was no upgrade of K-TIRADS category or any newly diagnosed malignancy during the follow-up period. Conclusion: US-guided CNB-confirmed benign thyroid nodules with inconclusive cytology on FNA showed a stable status during follow-up, and repeated CNB could be helpful in the management of nodules with inconclusive cytology on FNA. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC ULTRASOUND MEDICINE | - |
dc.title | Follow-up of benign thyroid nodules confirmed by ultrasound-guided core needle biopsy after inconclusive cytology on fine-needle aspiration biopsy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Jeong Seon | - |
dc.identifier.doi | 10.14366/usg.22115 | - |
dc.identifier.scopusid | 2-s2.0-85145574915 | - |
dc.identifier.wosid | 000891595200001 | - |
dc.identifier.bibliographicCitation | ULTRASONOGRAPHY, v.42, no.1, pp.121 - 128 | - |
dc.relation.isPartOf | ULTRASONOGRAPHY | - |
dc.citation.title | ULTRASONOGRAPHY | - |
dc.citation.volume | 42 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 121 | - |
dc.citation.endPage | 128 | - |
dc.type.rims | ART | - |
dc.type.docType | Article; Early Access | - |
dc.identifier.kciid | ART002917365 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | RADIOLOGY CONSENSUS STATEMENT | - |
dc.subject.keywordPlus | IMAGING-BASED MANAGEMENT | - |
dc.subject.keywordPlus | MALIGNANCY RISK | - |
dc.subject.keywordPlus | KOREAN SOCIETY | - |
dc.subject.keywordPlus | DATA SYSTEM | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordAuthor | Thyroid nodule | - |
dc.subject.keywordAuthor | Biopsy | - |
dc.subject.keywordAuthor | Core needle | - |
dc.subject.keywordAuthor | Ultrasonography | - |
dc.subject.keywordAuthor | Benign | - |
dc.identifier.url | https://www.e-ultrasonography.org/journal/view.php?doi=10.14366/usg.22115 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.